Copyright Reports & Markets. All rights reserved.

Global Cell-based Assay Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Cell-based Assay Industry
  • 1.7 COVID-19 Impact: Cell-based Assay Market Trends

    • 2 Global Cell-based Assay Quarterly Market Size Analysis

    • 2.1 Cell-based Assay Business Impact Assessment - COVID-19
      • 2.1.1 Global Cell-based Assay Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Cell-based Assay Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Cell-based Assay Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Cell-based Assay Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Cell-based Assay Market
    • 3.4 Key Players Cell-based Assay Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Cell-based Assay Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Consumable
      • 1.4.2 Instrument
      • 1.4.3 Service and Software
    • 4.2 By Type, Global Cell-based Assay Market Size, 2019-2021

    5 Impact of Covid-19 on Cell-based Assay Segments, By Application

    • 5.1 Overview
      • 5.5.1 Pharmaceutical & Biotechnology
      • 5.5.2 Academic & Government Research Institutes
      • 5.5.3 Contract Research Organizations
      • 5.5.4 Others
    • 5.2 By Application, Global Cell-based Assay Market Size, 2019-2021
      • 5.2.1 By Application, Global Cell-based Assay Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Perkin Elmer
      • 7.1.1 Perkin Elmer Business Overview
      • 7.1.2 Perkin Elmer Cell-based Assay Quarterly Revenue, 2020
      • 7.1.3 Perkin Elmer Cell-based Assay Product Introduction
      • 7.1.4 Perkin Elmer Response to COVID-19 and Related Developments
    • 7.2 Sigma-Aldrich
      • 7.2.1 Sigma-Aldrich Business Overview
      • 7.2.2 Sigma-Aldrich Cell-based Assay Quarterly Revenue, 2020
      • 7.2.3 Sigma-Aldrich Cell-based Assay Product Introduction
      • 7.2.4 Sigma-Aldrich Response to COVID-19 and Related Developments
    • 7.3 Life Technologies ( a subsidiary of Thermo Fisher Scientific)
      • 7.3.1 Life Technologies ( a subsidiary of Thermo Fisher Scientific) Business Overview
      • 7.3.2 Life Technologies ( a subsidiary of Thermo Fisher Scientific) Cell-based Assay Quarterly Revenue, 2020
      • 7.3.3 Life Technologies ( a subsidiary of Thermo Fisher Scientific) Cell-based Assay Product Introduction
      • 7.3.4 Life Technologies ( a subsidiary of Thermo Fisher Scientific) Response to COVID-19 and Related Developments
    • 7.4 Agilent Technologies
      • 7.4.1 Agilent Technologies Business Overview
      • 7.4.2 Agilent Technologies Cell-based Assay Quarterly Revenue, 2020
      • 7.4.3 Agilent Technologies Cell-based Assay Product Introduction
      • 7.4.4 Agilent Technologies Response to COVID-19 and Related Developments
    • 7.5 Attana
      • 7.5.1 Attana Business Overview
      • 7.5.2 Attana Cell-based Assay Quarterly Revenue, 2020
      • 7.5.3 Attana Cell-based Assay Product Introduction
      • 7.5.4 Attana Response to COVID-19 and Related Developments
    • 7.6 BioTek Instruments
      • 7.6.1 BioTek Instruments Business Overview
      • 7.6.2 BioTek Instruments Cell-based Assay Quarterly Revenue, 2020
      • 7.6.3 BioTek Instruments Cell-based Assay Product Introduction
      • 7.6.4 BioTek Instruments Response to COVID-19 and Related Developments
    • 7.7 BioVision
      • 7.7.1 BioVision Business Overview
      • 7.7.2 BioVision Cell-based Assay Quarterly Revenue, 2020
      • 7.7.3 BioVision Cell-based Assay Product Introduction
      • 7.7.4 BioVision Response to COVID-19 and Related Developments
    • 7.8 BMG LABTECH
      • 7.8.1 BMG LABTECH Business Overview
      • 7.8.2 BMG LABTECH Cell-based Assay Quarterly Revenue, 2020
      • 7.8.3 BMG LABTECH Cell-based Assay Product Introduction
      • 7.8.4 BMG LABTECH Response to COVID-19 and Related Developments
    • 7.9 Cayman Chemical
      • 7.9.1 Cayman Chemical Business Overview
      • 7.9.2 Cayman Chemical Cell-based Assay Quarterly Revenue, 2020
      • 7.9.3 Cayman Chemical Cell-based Assay Product Introduction
      • 7.9.4 Cayman Chemical Response to COVID-19 and Related Developments
    • 7.10 Cisbio Bioassays
      • 7.10.1 Cisbio Bioassays Business Overview
      • 7.10.2 Cisbio Bioassays Cell-based Assay Quarterly Revenue, 2020
      • 7.10.3 Cisbio Bioassays Cell-based Assay Product Introduction
      • 7.10.4 Cisbio Bioassays Response to COVID-19 and Related Developments
    • 7.11 Corning
      • 7.11.1 Corning Business Overview
      • 7.11.2 Corning Cell-based Assay Quarterly Revenue, 2020
      • 7.11.3 Corning Cell-based Assay Product Introduction
      • 7.11.4 Corning Response to COVID-19 and Related Developments
    • 7.12 DiscoveRx
      • 7.12.1 DiscoveRx Business Overview
      • 7.12.2 DiscoveRx Cell-based Assay Quarterly Revenue, 2020
      • 7.12.3 DiscoveRx Cell-based Assay Product Introduction
      • 7.12.4 DiscoveRx Response to COVID-19 and Related Developments
    • 7.13 F. Hoffmann-La Roche
      • 7.13.1 F. Hoffmann-La Roche Business Overview
      • 7.13.2 F. Hoffmann-La Roche Cell-based Assay Quarterly Revenue, 2020
      • 7.13.3 F. Hoffmann-La Roche Cell-based Assay Product Introduction
      • 7.13.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments
    • 7.14 ProQinase
      • 7.14.1 ProQinase Business Overview
      • 7.14.2 ProQinase Cell-based Assay Quarterly Revenue, 2020
      • 7.14.3 ProQinase Cell-based Assay Product Introduction
      • 7.14.4 ProQinase Response to COVID-19 and Related Developments
    • 7.15 XENOMETRIX
      • 7.15.1 XENOMETRIX Business Overview
      • 7.15.2 XENOMETRIX Cell-based Assay Quarterly Revenue, 2020
      • 7.15.3 XENOMETRIX Cell-based Assay Product Introduction
      • 7.15.4 XENOMETRIX Response to COVID-19 and Related Developments
    • 7.16 Molecular Devices
      • 7.16.1 Molecular Devices Business Overview
      • 7.16.2 Molecular Devices Cell-based Assay Quarterly Revenue, 2020
      • 7.16.3 Molecular Devices Cell-based Assay Product Introduction
      • 7.16.4 Molecular Devices Response to COVID-19 and Related Developments
    • 7.17 Pall Corporation
      • 7.17.1 Pall Corporation Business Overview
      • 7.17.2 Pall Corporation Cell-based Assay Quarterly Revenue, 2020
      • 7.17.3 Pall Corporation Cell-based Assay Product Introduction
      • 7.17.4 Pall Corporation Response to COVID-19 and Related Developments
    • 7.18 Promega Corporation
      • 7.18.1 Promega Corporation Business Overview
      • 7.18.2 Promega Corporation Cell-based Assay Quarterly Revenue, 2020
      • 7.18.3 Promega Corporation Cell-based Assay Product Introduction
      • 7.18.4 Promega Corporation Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Cell-based Assay, including the following market information:
      Global Cell-based Assay Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Cell-based Assay Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Cell-based Assay Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Cell-based Assay Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Perkin Elmer, Sigma-Aldrich, Life Technologies ( a subsidiary of Thermo Fisher Scientific), Agilent Technologies, Attana, BioTek Instruments, BioVision, BMG LABTECH, Cayman Chemical, Cisbio Bioassays, Corning, DiscoveRx, F. Hoffmann-La Roche, ProQinase, XENOMETRIX, Molecular Devices, Pall Corporation, Promega Corporation, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Consumable
      Instrument
      Service and Software

      Based on the Application:
      Pharmaceutical & Biotechnology
      Academic & Government Research Institutes
      Contract Research Organizations
      Others

      Buy now